T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESL
1326
DELISTED
Esterline Technologies
ESL
| $10.5M | ﹤0.01% |
91,490
-1,500
| -2% | -$170K |
|
1327
Allegion
ALLE
$14.2B
| $10.4M | ﹤0.01% |
170,313
+1,685
| +1% | +$96.3K |
|
|
CLLS
1328
Cellectis
CLLS
$320M
| $10.4M | ﹤0.01% |
+300,000
| New | +$10.9M |
|
|
AIV
1329
Aimco
AIV
$379M
| $10.3M | ﹤0.01% |
1,956,236
+67,697
| +4% | +$352K |
|
1330
Criteo S.A. Ordinary Shares
CRTO
$915M
| $10.2M | ﹤0.01% |
+259,005
| New | +$10.8M |
|
1331
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.44B
| $9.98M | ﹤0.01% |
+545,810
| New | +$8.68M |
|
|
ADVS
1332
DELISTED
Advent Software Inc
ADVS
| $9.97M | ﹤0.01% |
226,000
-19,200
| -8% | -$790K |
|
|
BBNK
1333
DELISTED
BRIDGE CAPITAL HOLDINGS
BBNK
| $9.89M | ﹤0.01% |
378,990
-49,171
| -11% | -$1.13M |
|
|
TEG
1334
DELISTED
INTEGRYS ENERGY GROUP INC COM (USA)
TEG
| $9.89M | ﹤0.01% |
137,384
+3,380
| +3% | +$259K |
|
|
AJRD
1335
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $9.89M | ﹤0.01% |
426,610
+139,100
| +48% | +$2.68M |
|
1336
Exponent
EXPO
$3.24B
| $9.89M | ﹤0.01% |
444,816
+81,600
| +22% | +$1.75M |
|
|
GRMN
1337
Garmin
GRMN
$60.2B
| $9.82M | ﹤0.01% |
206,590
-10
| -0% | -$510 |
|
1338
Dick's Sporting Goods
DKS
$18.1B
| $9.77M | ﹤0.01% |
171,396
-13,660
| -7% | -$749K |
|
|
AFSI
1339
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $9.73M | ﹤0.01% |
341,586
-10,600
| -3% | -$287K |
|
|
TYPE
1340
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $9.72M | ﹤0.01% |
297,720
+2,431
| +0.8% | +$75.2K |
|
1341
Nasdaq
NDAQ
$54.6B
| $9.62M | ﹤0.01% |
566,370
+13,170
| +2% | +$214K |
|
1342
Deckers Outdoor
DECK
$12.7B
| $9.53M | ﹤0.01% |
784,560
-30,570
| -4% | -$393K |
|
1343
Opko Health
OPK
$1.04B
| $9.52M | ﹤0.01% |
671,700
+107,800
| +19% | +$1.4M |
|
|
ICON
1344
DELISTED
Iconix Brand Group, Inc.
ICON
| $9.48M | ﹤0.01% |
28,155
+230
| +0.8% | +$79K |
|
1345
Howard Hughes
HHH
$4.04B
| $9.48M | ﹤0.01% |
64,120
-5,770
| -8% | -$759K |
|
|
OPLN
1346
Openlane
OPLN
$4.33B
| $9.38M | ﹤0.01% |
653,187
-40,132
| -6% | -$544K |
|
|
QVCGA
1347
DELISTED
QVC Group Inc Series A
QVCGA
| $9.35M | ﹤0.01% |
6,596
-392
| -6% | -$546K |
|
1348
ICU Medical
ICUI
$4.58B
| $9.32M | ﹤0.01% |
100,100
+5,400
| +6% | +$472K |
|
1349
Walker & Dunlop
WD
$1.47B
| $9.31M | ﹤0.01% |
525,243
+4,490
| +0.9% | +$76.2K |
|
|
RVBD
1350
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
| $9.26M | ﹤0.01% |
442,835
-57,500
| -11% | -$1.19M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.